← Back to Screener
Hims & Hers Health, Inc. (HIMS)
Price$28.82
Favorite Metrics
Price vs S&P 500 (26W)-55.33%
Price vs S&P 500 (4W)21.39%
Market Capitalization$6.57B
P/E Ratio (Annual)51.18x
All Metrics
P/CF (Annual)21.90x
Book Value / Share (Quarterly)$2.38
P/TBV (Annual)21.44x
Revenue Growth (3Y)64.55%
Cash Flow / Share (Quarterly)$0.25
Price vs S&P 500 (YTD)-15.38%
Gross Margin (TTM)73.84%
Net Profit Margin (TTM)5.47%
EPS (TTM)$0.51
10-Day Avg Trading Volume32.10M
EPS Excl Extra (TTM)$0.51
EPS (Annual)$0.50
ROI (Annual)8.48%
Gross Margin (Annual)73.84%
Net Profit Margin (5Y Avg)-8.15%
Cash / Share (Quarterly)$2.54
P/E Basic Excl Extra (TTM)51.18x
Revenue Growth QoQ (YoY)28.41%
EPS Growth (5Y)63.46%
P/E Normalized (Annual)51.18x
ROA (Last FY)5.96%
Revenue Growth TTM (YoY)59.00%
EBITD / Share (TTM)$0.63
ROE (5Y Avg)-1.98%
Operating Margin (TTM)4.50%
Cash Flow / Share (Annual)$0.25
P/B Ratio12.14x
P/B Ratio (Quarterly)13.66x
Net Income / Employee (Annual)$0
EV / Revenue (TTM)3.12x
ROA (TTM)7.17%
EPS Growth QoQ (YoY)-26.29%
EV / EBITDA (TTM)45.79x
EPS Incl Extra (Annual)$0.50
Current Ratio (Annual)1.90x
Quick Ratio (Quarterly)1.61x
3-Month Avg Trading Volume29.44M
52-Week Price Return6.94%
EV / Free Cash Flow (Annual)127.37x
P/E Incl Extra (TTM)51.18x
Revenue / Employee (TTM)$1
Tangible BV / Share (Quarterly)$1.52
P/S Ratio (Annual)2.80x
Asset Turnover (Annual)1.09x
52-Week High$70.43
Operating Margin (5Y Avg)-10.02%
EPS Excl Extra (Annual)$0.50
26-Week Price Return-46.58%
Quick Ratio (Annual)1.61x
13-Week Price Return-7.98%
Total Debt / Equity (Annual)1.80x
Current Ratio (Quarterly)1.90x
Enterprise Value$7,313.159
Asset Turnover (TTM)1.31x
Book Value / Share Growth (5Y)-20.91%
Revenue / Employee (Annual)$1
Inventory Turnover (Annual)8.50x
Pretax Margin (Annual)5.28%
Cash / Share (Annual)$2.54
3-Month Return Std Dev121.45%
Gross Margin (5Y Avg)77.61%
Net Income / Employee (TTM)$0
ROE (Last FY)23.73%
EPS Basic Excl Extra (Annual)$0.50
P/FCF (TTM)34.77x
Receivables Turnover (TTM)122.82x
EV / Free Cash Flow (TTM)127.37x
Total Debt / Equity (Quarterly)1.80x
EPS Incl Extra (TTM)$0.51
Receivables Turnover (Annual)122.82x
ROI (TTM)9.98%
P/S Ratio (TTM)2.80x
Pretax Margin (5Y Avg)-9.11%
Revenue / Share (Annual)$9.09
Tangible BV / Share (Annual)$1.52
Forward P/E56.12x
Price vs S&P 500 (52W)-28.16%
P/E Ratio (TTM)51.18x
EPS Growth TTM (YoY)-4.65%
Year-to-Date Return-11.24%
5-Day Price Return36.26%
EPS Normalized (Annual)$0.50
ROA (5Y Avg)-5.02%
Net Profit Margin (Annual)5.47%
Month-to-Date Return38.82%
Cash Flow / Share (TTM)$-0.13
EBITD / Share (Annual)$0.62
Operating Margin (Annual)4.50%
LT Debt / Equity (Annual)1.80x
P/CF (TTM)21.90x
ROI (5Y Avg)-5.03%
P/E Excl Extra (TTM)51.18x
LT Debt / Equity (Quarterly)1.80x
EPS Basic Excl Extra (TTM)$0.51
P/TBV (Quarterly)21.44x
P/B Ratio (Annual)13.66x
Inventory Turnover (TTM)8.50x
Pretax Margin (TTM)5.28%
Book Value / Share (Annual)$2.38
Price vs S&P 500 (13W)-10.85%
Beta2.54x
P/FCF (Annual)114.42x
Revenue / Share (TTM)$8.82
ROE (TTM)22.99%
52-Week Low$13.74
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
3.38
3.36
2.71
3.50
Industry Peers — Physicians' Offices(9)
| Symbol | P/E Ratio (Annual) | Revenue Growth TTM (YoY) | Operating Margin (TTM) | ROE (TTM) | Price |
|---|---|---|---|---|---|
HIMSHims & Hers Health, Inc. | 51.18x | 59.00% | 4.50% | 22.99% | $28.82 |
TDOCTeladoc Health, Inc. | — | -1.54% | -10.39% | -14.24% | $5.69 |
SBCSBC Medical Group Holdings Incorporated Common Stock | 9.03x | — | 43.91% | 21.08% | $4.49 |
TOIThe Oncology Institute, Inc. Common Stock | — | 27.79% | -7.18% | -482.58% | $3.54 |
LFMDLifeMD, Inc. Common Stock | 13.67x | 10.59% | -3.28% | 132.06% | $4.09 |
LFMDPLifeMD, Inc. 8.875% Series A Cumulative Perpetual Preferred Stock | 13.67x | 10.59% | -3.28% | 132.06% | $23.92 |
AIRSAirSculpt Technologies, Inc. Common Stock | — | -15.82% | -7.61% | -13.79% | $2.56 |
AUNAAuna S.A. | 14.63x | -0.02% | 14.26% | 6.08% | $5.62 |
BMGLBasel Medical Group Ltd Ordinary Shares | — | — | -58.56% | -172.53% | $0.57 |
CCMConcord Medical Services Holding Limited | — | 40.12% | -90.64% | -11.58% | $3.93 |
About
Hims & Hers operates a U.S.-focused telehealth platform connecting patients with licensed healthcare professionals for treatments across sexual health, hair loss, hormone health, weight loss, dermatology, and mental health, supplemented by laboratory testing and wellness products. Prescriptions are fulfilled through licensed online pharmacies, generating revenue from prescription services, testing, and product sales. The mobile platform also provides educational content, community support, and wellness programs that drive patient engagement.